Instrumento Inactivo

Otros idiomas Enzon Pharmaceuticals Inc Nasdaq

Acciones

US2939041081

Precio de cierre Nasdaq Otros sitios de cotización
- ^USD	-

10/05	Enzon Pharmaceuticals, Inc. informa de los resultados del primer trimestre finalizado el 31 de marzo de 2024	CI
20/03	Enzon Pharmaceuticals, Inc. informa de los resultados de las ganancias para el año completo finalizado el 31 de diciembre de 2023	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Enzon Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	10/05
Enzon Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	20/03
Enzon Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11
Enzon Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	07/08/23
ENZON PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	05/05/23
Enzon Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	05/05/23
ENZON PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	16/02/23
Enzon Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	16/02/23
ENZON PHARMACEUTICALS, INC. : Other Events (form 8-K)	06/01/23
ENZON PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	09/11/22
Enzon Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	09/11/22
ENZON PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	04/08/22
Enzon Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	04/08/22
ENZON PHARMACEUTICALS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	15/06/22
ENZON PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	26/04/22
Enzon Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	26/04/22
ENZON PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	25/02/22
Enzon Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	25/02/22
ENZON PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	05/11/21
Enzon Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	05/11/21

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Enzon Pharmaceuticals Inc Nasdaq

Acciones

US2939041081

Otros idiomas

Filtros